Latent factor in Brain RNA-seq studies reflects cell type and clinical heterogeneity
Liu, Z.; Al-Ouran, R.; Liu, C.; Wang, L.; Wan, Y.; Li, X.; Milosavljevic, A.; Shulman, J.
Show abstract
With the growing availability of Alzheimers disease (AD) transcriptomic data, several studies have nominated new therapeutic targets. However, a major challenge is accounting for latent (hidden) factors which affect the discovery of therapeutic targets. Using unsupervised machine learning, we identified a latent factor in brain tissue, and we validated the factor in AD and normal samples, across multiple studies, and different brain tissues. Moreover, significant metabolic differences were observed due to the latent factor. The latent factor was found to reflect cell-type heterogeneity in the brain and after adjusting for it, we were able to identify new biological pathways. The changes observed at both transcriptomic and metabolomic levels support the importance of identifying any latent factors before pursuing downstream analysis to accurately identify biomarkers.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- A public resource of single cell transcriptomes and multiscale networks from persons with and without Alzheimer's disease 97%
- Deep clinical phenotyping of Alzheimer’s Disease Patients Leveraging Electronic Medical Records Data Identifies Sex-Specific Clinical Associations 96%
- Molecular Signatures of Resilience to Alzheimer's Disease in Neocortical Layer 4 Neurons 96%
Similar papers in this journal
- Manifestations of genetic risk for Alzheimer's Disease in the blood: a cross-sectional multi-omic analysis in healthy adults aged 18-90+ 96%
- PTPRS is a novel marker for early tau pathology and synaptic integrity in Alzheimer's disease 94%
- Novel Alzheimer's disease genes and epistasis identified using machine learning GWAS platform 94%
Similar papers in this journal
- Integrative Network Analysis Reveals Novel Moderators of Aβ-Tau Interaction in Alzheimer's Disease 98%
- Network medicine links SARS-CoV-2/COVID-19 infection to brain microvascular injury and neuroinflammation in dementia-like cognitive impairment 95%
- Challenges at the APOE locus: A robust quality control approach for accurate APOE genotyping 94%
Similar papers in this journal
- Knockout of the longevity gene Klotho perturbs aging- and Alzheimer's disease-linked brain microRNAs and tRNA fragments 96%
- Improving genetic risk modeling of dementia from real-world data in underrepresented populations 94%
- Partial inhibition of mitochondrial complex I attenuates neurodegeneration and restores energy homeostasis and synaptic function in a symptomatic Alzheimers mouse model 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.